Cancer chemotherapy: targeting folic acid synthesis

por Hagner, Nicole, Joerger, Markus
Publicado 2010

New antibody-drug conjugates (ADCs) in breast cancer—an overview of ADCs recently approved and in later stages of development

por Koster, Kira-Lee, Huober, Jens, Joerger, Markus
Publicado 2022

Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors

por Gachechiladze, Mariam, Skarda, Josef, Bouchalova, Katerina, Soltermann, Alex, Joerger, Markus
Publicado 2020

24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling

por Baty, Florent, Joerger, Markus, Früh, Martin, Klingbiel, Dirk, Zappa, Francesco, Brutsche, Martin
Publicado 2017

A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction

por Warschkow, Rene, Cerny, Thomas, Schmied, Bruno M, Güller, Ulrich, Thuerlimann, Beat, Joerger, Markus
Publicado 2016

Non-pharmaceutical interventions to optimize cancer immunotherapy

por Boesch, Maximilian, Baty, Florent, Rassouli, Frank, Kowatsch, Tobias, Joerger, Markus, Früh, Martin, Brutsche, Martin H.
Publicado 2023

Radiotherapy for thymic epithelial tumours: a review

por Süveg, Krisztian, Putora, Paul Martin, Joerger, Markus, Iseli, Thomas, Fischer, Galina Farina, Ammann, Karlheinz, Glatzer, Markus
Publicado 2021

Tumour neoantigen mimicry by microbial species in cancer immunotherapy

por Boesch, Maximilian, Baty, Florent, Rothschild, Sacha I., Tamm, Michael, Joerger, Markus, Früh, Martin, Brutsche, Martin H.
Publicado 2021

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer

por Crombag, Marie-Rose B.S., Joerger, Markus, Thürlimann, Beat, Schellens, Jan H.M., Beijnen, Jos H., Huitema, Alwin D.R.
Publicado 2016

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen

por Klopp-Schulze, Lena, Mueller-Schoell, Anna, Neven, Patrick, Koolen, Stijn L. W., Mathijssen, Ron H. J., Joerger, Markus, Kloft, Charlotte
Publicado 2020

A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies

por Schaerer, Dominic, Froehlich, Tanja K., Hamzic, Seid, Offer, Steven M., Diasio, Robert B., Joerger, Markus, Amstutz, Ursula, Largiadèr, Carlo R.
Publicado 2020

Pembrolizumab-Associated CD8(+) Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma

por Baldauf, Michaela C., Kapauer, Monika, Joerger, Markus, Flatz, Lukas, Rodriguez, Regulo, Frank, Stephan, Felbecker, Ansgar, Hartmann-Fussenegger, Susanne, Hundsberger, Thomas
Publicado 2021

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer

por Boesch, Maximilian, Baty, Florent, Albrich, Werner C., Flatz, Lukas, Rodriguez, Regulo, Rothschild, Sacha I., Joerger, Markus, Früh, Martin, Brutsche, Martin H.
Publicado 2021

A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non‐small cell lung cancer patients

por Ojara, Francis Williams, Henrich, Andrea, Frances, Nicolas, Nassar, Yomna M., Huisinga, Wilhelm, Hartung, Niklas, Geiger, Kimberly, Holdenrieder, Stefan, Joerger, Markus, Kloft, Charlotte
Publicado 2023

C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework

por Nassar, Yomna M., Ojara, Francis Williams, Pérez-Pitarch, Alejandro, Geiger, Kimberly, Huisinga, Wilhelm, Hartung, Niklas, Michelet, Robin, Holdenrieder, Stefan, Joerger, Markus, Kloft, Charlotte
Publicado 2023

Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study

por Joerger, Markus, Hundsberger, Thomas, Haefliger, Simon, von Moos, Roger, Hottinger, Andreas F., Kaindl, Thomas, Engelhardt, Marc, Marszewska, Michalina, Lane, Heidi, Roth, Patrick, Stathis, Anastasios
Publicado 2023

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies

por Mueller-Schoell, Anna, Klopp-Schulze, Lena, Michelet, Robin, van Dyk, Madelé, Mürdter, Thomas E., Schwab, Matthias, Joerger, Markus, Huisinga, Wilhelm, Mikus, Gerd, Kloft, Charlotte
Publicado 2021

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups

por Mueller-Schoell, Anna, Michelet, Robin, Klopp-Schulze, Lena, van Dyk, Madelé, Mürdter, Thomas E., Schwab, Matthias, Joerger, Markus, Huisinga, Wilhelm, Mikus, Gerd, Kloft, Charlotte
Publicado 2021

Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs

por Herbrand, Amanda Katherina, Schmitt, Andreas M., Briel, Matthias, Ewald, Hannah, Goldkuhle, Marius, Diem, Stefan, Hoogkamer, Anouk, Joerger, Markus, Moffa, Giusi, Novak, Urban, Hemkens, Lars G., Kasenda, Benjamin
Publicado 2021

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

por Joerger, Markus, Calvo, Emiliano, Laubli, Heinz, Lopez, Juanita, Alonso, Guzmán, Corral de la Fuente, Elena, Hess, Dagmar, König, David, Sanchez Perez, Vicky, Bucher, Christoph, Jethwa, Sangeeta, Garralda, Elena
Publicado 2023